Skip to main content

The Oncology Pharmacist® features articles written by and for oncology pharmacists and specifically addresses the issues pharmacists and their colleagues face every day in clinical practice.

Featured Articles


Featured Video

Who Are the Patients with Multiple Myeloma Who May Not Adhere to Their Treatment Regimen?

Charise Gleason, MSN, NP-C, AOCNP, and Nikki Barkett, RN, BSN, OCN, talk about the clues and the patient characteristics that they use to determine which of their patients with multiple myeloma may be at risk for not adhering to their anticancer therapy.


  • November is Pancreatic Cancer Awareness Month. Take our quiz and explore our articles to stay up to date on pancreatic cancer.

    Quick Quiz View Pancreatic Cancer Articles
  • Pancreatic Cancer

    It is estimated that approximately 64,050 individuals (33,130 men and 30,920 women) in the United States will be diagnosed with pancreatic cancer in 2023, and approximately 50,550 individuals (26,620 men and 23,930 women) will die from the disease. How much do you know about pancreatic cancer?

  • Lorazepam Treatment May Be Linked to Worse Outcomes for Pancreatic Cancer Patients

    According to recent results published in Clinical Cancer Research, patients with pancreatic cancer who took the benzodiazepine lorazepam (Ativan), commonly prescribed to treat anxiety during cancer treatment, had a shorter progression-free survival than patients who did not.